| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/21/2026 | ±2.1% | -2.3% | under-priced |
| 07/21/2026 | ±7.4% | -0.9% | over-priced |
| 04/22/2026 | ±3.1% | +7.2% | under-priced |
| 02/03/2026 | ±2.3% | -3.6% | under-priced |
| 10/22/2025 | ±2.4% | +13.9% | under-priced |
| 07/23/2025 | ±1.8% | -1.8% | under-priced |
| 04/23/2025 | ±3.0% | +1.9% | over-priced |
| 01/31/2025 | ±3.4% | -1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.49 | $3.0B | $523M |
| Q2 FY2026 | $2.29 | $2.9B | $818M |
| Q1 FY2026 | $2.28 | $2.8B | $822M |
| Q4 FY2025 | — | $2.9B | $795M |
Intuitive Surgical, Inc. Common Stock (ISRG) reports in 84 days, with the next report estimated for 01/20/2027. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 4.1% on average — the market has been roughly fair on ISRG's earnings risk. Fundamentals into the print: EPS down 23.6% year-over-year, revenue up 21.7%. QuantLogix's live 5-factor engine currently reads ISRG as a neutral at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →